Evidence map›Paper›PMID 40275516›Full record

ArticleInfluenza and other respiratory viruses2025

SARS-CoV-2 Anti-S an Anti-N IgG Seropositivity in Children and Young People (1-24 Years) According to HIV Status in Lomé (Togo) in 2022.

Yao Rodion Konu, Florence Damond, I Wone Oumarou Adama, Valentine Marie Ferré, Alassane Ouro-Médéli, Ounoo Elom Takassi, Nina Dapam, Magnoulélén N'zonou, Ridwane Bawa-Kawte, Martin Kouame Tchankoni and 5 more

Abstract readComparative StudyMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Influenza and other respiratory viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yao Rodion KonuCentre de Formation et de Recherche en Santé Publique, Département de Santé Publique, Faculté des Science de la Santé, Université de Lomé, Lomé, Togo.ORCID 0000-0002-0506-0008
Florence DamondService de Virologie, Université Paris Cité, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France.
I Wone Oumarou AdamaGHiGS Team, University of Bordeaux, Inserm (UMR 1219), IRD (EMR 279), Bordeaux Population Health Centre, Bordeaux, France.
Valentine Marie FerréService de Virologie, Université Paris Cité, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France.
Alassane Ouro-MédéliCentre national de recherche sur le VIH, Programme National de Lutte contre le VIH et les hépatites virales, Lomé, Togo.
Ounoo Elom TakassiService de pédiatrie, CHU Sylvanus Olympio, Lomé, Togo.
Nina DapamCentre Médicosocial Lucia, ONG Espoir Vie Togo, Lomé, Togo.
Magnoulélén N'zonouService de pédiatrie, Hopital de Bè, Lomé, Togo.
Ridwane Bawa-KawteCentre médicosocial de l'ONG Action Communautaire pour la Santé, Lomé, Togo.
Martin Kouame TchankoniCentre de Formation et de Recherche en Santé Publique, Département de Santé Publique, Faculté des Science de la Santé, Université de Lomé, Lomé, Togo.
Arnold Junior SadioCentre de Formation et de Recherche en Santé Publique, Département de Santé Publique, Faculté des Science de la Santé, Université de Lomé, Lomé, Togo.
Fatoumata Binta Tidiane DialloWorld Health Organization Country Office (WCO), Lomé, Togo.
Claver Anoumou DagnraCentre national de recherche sur le VIH, Programme National de Lutte contre le VIH et les hépatites virales, Lomé, Togo.
Charlotte CharpentierService de Virologie, Université Paris Cité, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France.ORCID 0000-0002-6441-7054
Didier Koumavi EkoueviCentre de Formation et de Recherche en Santé Publique, Département de Santé Publique, Faculté des Science de la Santé, Université de Lomé, Lomé, Togo.

Funding

Agence Nationale de Recherche sur le sida et les hépatites virales (ANRS)World Health Organization 001World Health Organization Country Office of Togo 2022/1307691-0
6 · The paper itself

Abstract

We aimed to estimate SARS-CoV-2 seropositivity among children and young people in Lomé, Togo, according to HIV status. A multicenter comparative cross-sectional study was conducted, and 636 participants were included (41.8% living with HIV). Anti-S (88.7% vs. 89.1%) and anti-N (41.6% vs. 39.5%) IgG seropositivity were comparable in both groups. These data suggest no increased COVID-19 susceptibility in children and young people with HIV.

Indexed as

Antibodies, ViralCoronavirus Nucleocapsid ProteinsCOVID-19HIV InfectionsImmunoglobulin GSARS-CoV-2Spike Glycoprotein, CoronavirusAdolescentChildChild, PreschoolCross-Sectional StudiesFemaleHumansInfantMaleTogoAntibodies, ViralCoronavirus Nucleocapsid ProteinsImmunoglobulin GSpike Glycoprotein, CoronavirusHIVSARS‐CoV‐2seropositivityyoung people

Identifiers

PMID40275516
PMCPMC12022004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.